The effects of recombinant human granulocyte-macrophage colony-stimulating factor on the induction of lymphokine-activated killer cells in vitro
- 31 December 1991
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 13 (5) , 587-593
- https://doi.org/10.1016/0192-0561(91)90080-q
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Lymphokine-activated killer cell activity: Characteristics of effector cells and their progenitors in blood and spleenImmunology Today, 1987
- Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic SyndromesNew England Journal of Medicine, 1987
- Effect of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor on Myelopoiesis in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Secretory products of macrophages.Journal of Clinical Investigation, 1987
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Purification and characterization of recombinant human interleukin-2 produced in Escherichia coliBiochemical and Biophysical Research Communications, 1985
- Comparison of the biological properties of purified natural and recombinant human interleukin-2Biochemical and Biophysical Research Communications, 1985
- Translation of interleukin 2 mRNA from human peripheral blood leukocytes in Xenopus oocytesBiochemical and Biophysical Research Communications, 1982